Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuţă Oncology Institute series

BACKGROUND: The evolution of COVID-19 is a controversial topic in cancer patients. They have been designated by international organizations as a vulnerable population at greater risk for contracting SARS-CoV-2 and having a more severe clinical outcome. PATIENTS AND METHODS: Active screening at our i...

Descripción completa

Detalles Bibliográficos
Autores principales: Preda, A., Ciuleanu, T., Kubelac, P., Todor, N., Balacescu, O., Achimas-Cadariu, P., Iancu, D., Mocan, C., Bandi-Vasilica, M., Lupse, M., Briciu, V.T., Man, M.A., Vlad, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828430/
https://www.ncbi.nlm.nih.gov/pubmed/35279526
http://dx.doi.org/10.1016/j.esmoop.2022.100423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828430/
https://www.ncbi.nlm.nih.gov/pubmed/35279526
http://dx.doi.org/10.1016/j.esmoop.2022.100423

Ejemplares similares